Short-term symptomatic treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and other joint diseases accompanied by pain;
The drug is intended to reduce pain and inflammation at the time of use, does not affect the progression of the disease.
Intramuscular administration of the drug is indicated only during the first 2-3 days. Further treatment is continued with the use of oral forms (tablets).
The drug is administered deeply intramuscularly. Intravenous administration of the drug is prohibited!
Considering possible incompatibility, meloxicam should not be mixed in the same syringe with other drugs.
For patients with mild or moderate renal failure (CC more than 30 ml / min), dose adjustment is not required.
You should not use the drug simultaneously with other NSAID.
There are contraindications, consult with a specialist before use